RYVELA

RYTVELA is a deriviative of the peptide antagonist of interleukin-1 receptor 1 (IL-1R1) d- (RYTVELA) that contains all L-amino acids[1].

1200829-06-6

12352209

Drug Isomer

Others

Others

98.89

OC(C=C1)=CC=C1C[C@H](NC([C@@H](N)CCCNC(N)=N)=O)C(N[C@@H]([C@H](O)C)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CC(C)C)C(N[C@@H](C)C(O)=O)=O)=O)=O)=O)=O

C38H62N10O12

850.96

[1]Christiane Quiniou, et al. Interleukin-1 and ischemic brain injury in the newborn: Development of a small molecule inhibitor of IL-1 receptor. Semin. Semin Perinatol. 2008 Oct;32 (5) :325-33.

Blue Ice

-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)

http://file.medchemexpress.com/batch_PDF/HY-P10474/RYTVELA-SDS-MedChemExpress.pdf

Peptides

No Development Reported